Biochemistry (Moscow)

, Volume 73, Issue 11, pp 1183–1191

Functional significance of a putative Sp1 transcription factor binding site in the survivin gene promoter

  • M. V. Mityaev
  • E. P. Kopantzev
  • A. A. Buzdin
  • T. V. Vinogradova
  • E. D. Sverdlov
Accelerated Publication


We sequenced 1500-bp genomic DNA regions upstream from the survivin gene (BIRC5). DNA was isolated from human placenta and tumors of patients with diagnosed squamous cancer of the lung that showed high-level BIRC5 gene expression. We have revealed four new promoter allelic variants differing in single nucleotide substitutions, one variant with two nucleotide substitutions, and a variant with a TAAA tetranucleotide insertion. All promoter variants displayed low activity in cells with functionally active p53 protein and high activity in cell lines characterized by low level or absence of p53 protein function. The activity of the promoters with single nucleotide substitutions was comparable to that of the wild-type promoter, whereas two nucleotide substitutions markedly reduced the activity. We also demonstrated the functional significance of a putative Sp1 transcription factor-binding site at (−63...−54) upstream from the transcription initiation site. Mutation within this sequence led to a sharp decrease of promoter activity. The functional architecture of the survivin promoter is discussed based on results known from the literature and those obtained here.

Key words

survivin promoter regulation of promoter activity Sp1 binding sites SNP 



survivin gene


cell cycle-dependent element


single nucleotide polymorphism


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Henson, P. M., and Hume, D. A. (2006) Trends Immunol., 27, 244–250.PubMedCrossRefGoogle Scholar
  2. 2.
    Jacobson, M. D., Weil, M., and Raff, M. C. (1997) Cell, 88, 347–354.PubMedCrossRefGoogle Scholar
  3. 3.
    Vermeulen, K., van Bockstaele, D. R., and Berneman, Z. N. (2005) Ann. Hematol., 84, 627–639.PubMedCrossRefGoogle Scholar
  4. 4.
    Altieri, D. C. (2008) Nat. Rev. Cancer, 8, 61–70.PubMedCrossRefGoogle Scholar
  5. 5.
    Ambrosini, G., Adida, C., and Altieri, D. C. (1997) Nat. Med., 3, 917–921.PubMedCrossRefGoogle Scholar
  6. 6.
    Fukuda, S., and Pelus, L. M. (2006) Mol. Cancer Ther., 5, 1087–1098.PubMedCrossRefGoogle Scholar
  7. 7.
    Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., and Altieri, D. C. (1998) Nature, 396, 580–584.PubMedCrossRefGoogle Scholar
  8. 8.
    Jiang, Y., Saavedra, H. I., Holloway, M. P., Leone, G., and Altura, R. A. (2004) J. Biol. Chem., 279, 40511–40520.PubMedCrossRefGoogle Scholar
  9. 9.
    Raj, D., Liu, T., Samadashwily, G., Li, F., and Grossman, D. (2008) Carcinogenesis, 29, 194–201.PubMedCrossRefGoogle Scholar
  10. 10.
    Wagner, M., Schmelz, K., Dorken, B., and Tamm, I. (2008) Int. J. Cancer, 122, 1278–1287.PubMedCrossRefGoogle Scholar
  11. 11.
    Cosgrave, N., Hill, A. D., and Young, L. S. (2006) J. Mol. Endocrinol., 37, 377–390.PubMedCrossRefGoogle Scholar
  12. 12.
    Li, F., and Altieri, D. C. (1999) Biochem. J., 344,Pt. 2, 305–311.PubMedCrossRefGoogle Scholar
  13. 13.
    Xu, R., Zhang, P., Huang, J., Ge, S., Lu, J., and Qian, G. (2007) Biochem. Biophys. Res. Commun., 356, 286–292.PubMedCrossRefGoogle Scholar
  14. 14.
    Zhu, N., Gu, L., Findley, H. W., Chen, C., Dong, J. T., Yang, L., and Zhou, M. (2006) J. Biol. Chem., 281, 14711–14718.PubMedCrossRefGoogle Scholar
  15. 15.
    Li, Y., Xie, M., Yang, J., Yang, D., Deng, R., Wan, Y., and Yan, B. (2006) Oncogene, 25, 3296–3306.PubMedCrossRefGoogle Scholar
  16. 16.
    Peng, X. H., Karna, P., Cao, Z., Jiang, B. H., Zhou, M., and Yang, L. (2006) J. Biol. Chem., 281, 25903–25914.PubMedCrossRefGoogle Scholar
  17. 17.
    Esteve, P. O., Chin, H. G., and Pradhan, S. (2007) J. Biol. Chem., 282, 2615–2625.PubMedCrossRefGoogle Scholar
  18. 18.
    Grossman, D., Kim, P. J., Blanc-Brude, O. P., Brash, D. E., Tognin, S., Marchisio, P. C., and Altieri, D. C. (2001) J. Clin. Invest., 108, 991–999.PubMedGoogle Scholar
  19. 19.
    Mirza, A., McGuirk, M., Hockenberry, T. N., Wu, Q., Ashar, H., Black, S., Wen, S. F., Wang, L., Kirschmeier, P., Bishop, W. R., Nielsen, L. L., Pickett, C. B., and Liu, S. (2002) Oncogene, 21, 2613–2622.PubMedCrossRefGoogle Scholar
  20. 20.
    Briggs, M. R., Kadonaga, J. T., Bell, S. P., and Tjian, R. (1986) Science, 234, 47–52.PubMedCrossRefGoogle Scholar
  21. 21.
    Jang, J. S., Kim, K. M., Kang, K. H., Choi, J. E., Lee, W. K., Kim, C. H., Kang, Y. M., Kam, S., Kim, I. S., Jun, J. E., Jung, T. H., and Park, J. Y. (2008) Lung Cancer, 60, 31–39.PubMedCrossRefGoogle Scholar
  22. 22.
    Xu, Y., Fang, F., Ludewig, G., Jones, G., and Jones, D. (2004) DNA Cell Biol., 23, 527–537.PubMedGoogle Scholar
  23. 23.
    Borbely, A. A., Murvai, M., Szarka, K., Konya, J., Gergely, L., Hernadi, Z., and Veress, G. (2007) J. Clin. Pathol., 60, 303–306.PubMedCrossRefGoogle Scholar
  24. 24.
    Wagner, M., Schmelz, K., Dorken, B., and Tamm, I. (2008) Leuk. Res., 32, 1054–1060.PubMedCrossRefGoogle Scholar
  25. 25.
    Hattori, M., Sakamoto, H., Satoh, K., and Yamamoto, T. (2001) Cancer Lett., 169, 155–164.PubMedCrossRefGoogle Scholar
  26. 26.
    Adams, R. L. P. (1980) Cell Culture for Biochemists, Elsevier/North-Holland Biomedical Press, Amsterdam-New York.Google Scholar
  27. 27.
    Mashima, T., Oh-hara, T., Sato, S., Mochizuki, M., Sugimoto, Y., Yamazaki, K., Hamada, J., Tada, M., Moriuchi, T., Ishikawa, Y., Kato, Y., Tomoda, H., Yamori, T., and Tsuruo, T. (2005) J. Natl. Cancer Inst., 97, 765–777.PubMedCrossRefGoogle Scholar
  28. 28.
    Nicholson, S. A., Okby, N. T., Khan, M. A., Welsh, J. A., McMenamin, M. G., Travis, W. D., Jett, J. R., Tazelaar, H. D., Trastek, V., Pairolero, P. C., Corn, P. G., Herman, J. G., Liotta, L. A., Caporaso, N. E., and Harris, C. C. (2001) Cancer Res., 61, 5636–5643.PubMedGoogle Scholar
  29. 29.
    Scheffner, M., Munger, K., Byrne, J. C., and Howley, P. M. (1991) Proc. Natl. Acad. Sci. USA, 88, 5523–5527.PubMedCrossRefGoogle Scholar
  30. 30.
    Chen, J. Y., Funk, W. D., Wright, W. E., Shay, J. W., and Minna, J. D. (1993) Oncogene, 8, 2159–2166.PubMedGoogle Scholar
  31. 31.
    Kim, P. J., Plescia, J., Clevers, H., Fearon, E. R., and Altieri, D. C. (2003) Lancet, 362, 205–209.PubMedCrossRefGoogle Scholar
  32. 32.
    Ghaleb, A. M., Nandan, M. O., Chanchevalap, S., Dalton, W. B., Hisamuddin, I. M., and Yang, V. W. (2005) Cell Res., 15, 92–96.PubMedCrossRefGoogle Scholar

Copyright information

© MAIK Nauka 2008

Authors and Affiliations

  • M. V. Mityaev
    • 1
  • E. P. Kopantzev
    • 1
  • A. A. Buzdin
    • 1
  • T. V. Vinogradova
    • 1
  • E. D. Sverdlov
    • 1
  1. 1.Shemyakin-Ovchinnikov Institute of Bioorganic ChemistryRussian Academy of SciencesMoscowRussia

Personalised recommendations